These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
    Author: Healy ML, Dawson SJ, Murray RM, Zalcberg J, Jefford M.
    Journal: Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385.
    Abstract:
    Insulinomas are the most common hormone-producing pancreatic neuroendocrine tumours (NETs), and patients usually present with symptoms secondary to hypoglycaemia. Octreotide has been widely used in the symptomatic treatment of patients with pancreatic NETs, including insulinomas. We describe a case of a patient with a metastatic NET, subsequently identified as a malignant insulinoma, who developed severe hypoglycaemia after treatment with long-acting octreotide.
    [Abstract] [Full Text] [Related] [New Search]